Publications found:
73,128
Sort by:
Pulmonary Arterial Hypertension - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
383 pages
Anesthetic Effect - Pipeline Review, H1 2020
US$ 2,000.00
... . The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
97 pages
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2020
US$ 2,000.00
... . The Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Hypoactive Sexual Desire Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
52 pages
Friedreich Ataxia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Friedreich Ataxia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Friedreich Ataxia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
122 pages
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H1 2020
US$ 2,000.00
... . The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
124 pages
Chlamydia Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chlamydia Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chlamydia Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
78 pages
Hyperuricemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperuricemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperuricemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
82 pages
Male Infertility - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Male Infertility (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
37 pages
Pancreatic Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
3802 pages
Tinnitus - Pipeline Review, H1 2020
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
45 pages
Esophageal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Esophageal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Esophageal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1342 pages
Thyroid Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Thyroid Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Thyroid Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
885 pages
Bacterial Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
34 pages
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Peripheral Neuropathy (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
151 pages
Gastric Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastric Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastric Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
53 pages
Pancreatitis - Pipeline Review, H1 2020
US$ 2,000.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pancreatitis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Pancreatitis (Gastrointestinal) The guide covers the ...
March 2020
101 pages
Premature Labor (Tocolysis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Premature Labor (Tocolysis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Labor (Tocolysis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
53 pages
Rhabdomyosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rhabdomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rhabdomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
421 pages
Rhinovirus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rhinovirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rhinovirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
58 pages
Polycystic Ovarian Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
51 pages
Axillary Hyperhidrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
53 pages
Alcoholic Hepatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
101 pages
Contact Dermatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
43 pages
Hand, Foot and Mouth Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
46 pages
Retinopathy Of Prematurity - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Arterial Thrombosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
60 pages
Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
147 pages
Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
75 pages
Oligodendroglioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oligodendroglioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oligodendroglioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
156 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Proliferative Diabetic Retinopathy (PDR) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Sinusitis - Pipeline Review, H1 2020
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
117 pages
Schistosomiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Schistosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
42 pages
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Resistant Pseudomonas aeruginosa Infections (Infectious Disease), complete with analysis by stage of development ...
March 2020
58 pages
Uveal Melanoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
312 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
114 pages
Drug Overdose - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
79 pages
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ebolavirus Infections (Ebola Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
300 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
283 pages
Heavy Metal Poisoning - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
38 pages
Hypopharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
336 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
250 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
186 pages
Influenzavirus B Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
160 pages
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Malignant Pleural Effusion - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
49 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
102 pages
Fragile X Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
188 pages
Liver Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
69 pages
Achondroplasia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
60 pages
